Welcome to LookChem.com Sign In|Join Free

CAS

  • or

118-61-6

Post Buying Request

118-61-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

118-61-6 Usage

Description

Ethyl 2-hydroxdybenzoate is also known as Ethyl salicylate, which a kind of ester formed through the condensation between salicylic acid and ethanol. It can be used as a perfumery, artificial essence flavoring agent and used in cosmetics. It can also be used as analgesics, anti-inflammatory and antipyretic agents.

Chemical Properties

Different sources of media describe the Chemical Properties of 118-61-6 differently. You can refer to the following data:
1. clear colourless to pale yellow liquid
2. Ethyl salicylate is the ester formed by the condensation of salicylic acid and ethanol. It is a clear liquid that is sparingly soluble in water, but soluble in alcohol and ether. It has a pleasant odor resembling winter green and is used in perfumery and artificial flavors.
3. Ethyl salicylate has a characteristic aromatic odor similar to wintergreen. It tends to darken on exposure to light and air.

Occurrence

Reported found in raspberry, tomato, currants, rum, whiskey, red wine, plum brandy, Cape gooseberry, Feijoa fruit, papaya and scotch.

Uses

Different sources of media describe the Uses of 118-61-6 differently. You can refer to the following data:
1. manufacture of artificial perfumes.
2. Ethyl salicylate is a non-steroidal analgesic, anti-inflammatory and antirrheumatic drug. Its complexation with β-cyclodextrin was studied using reversed-phase liquid chromatography.
3. Ethyl salicylate may be used as an analytical standard for the determination of the analyte in biological fluids and topical formulation by chromatography-based techniques.

Preparation

By esterification of salicylic acid with ethyl alcohol and concentrated H2SO4 at 100°C in the presence of aluminum sulfate; by heating to the boil an alkaline solution of salicylic acid and ethyl p-toluenesulfonate.

Production Methods

Ethyl salicylate is found naturally in currants and strawberries . It is manufactured commercially by the esterification of salicylic acid with ethyl alcohol.

Taste threshold values

Taste characteristics at 10 ppm: sweet, wintergreen, spicy and anisic.

General Description

Ethyl salicylate was hydrolysed to salicylic acid by the use of an extractive electrospray ionisation (EESI) device.

Flammability and Explosibility

Notclassified

References

Sheu, Yaw-Wen, and Chein-Hsiun Tu. "Densities and viscosities of binary mixtures of ethyl acetoacetate, ethyl isovalerate, methyl benzoate, benzyl acetate, ethyl salicylate, and benzyl propionate with ethanol at T=(288.15, 298.15, 308.15, and 318.15) K." Journal of Chemical & Engineering Data 51.2 (2006): 545-553. Filippa, Mauricio, Matías I. Sancho, and Estela Gasull. "Encapsulation of methyl and ethyl salicylates by β-cyclodextrin: HPLC, UV–vis and molecular modeling studies." Journal of pharmaceutical and biomedical analysis 48.3 (2008): 969-973.

Check Digit Verification of cas no

The CAS Registry Mumber 118-61-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 8 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 118-61:
(5*1)+(4*1)+(3*8)+(2*6)+(1*1)=46
46 % 10 = 6
So 118-61-6 is a valid CAS Registry Number.

118-61-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A10101)  Ethyl salicylate, 99%   

  • 118-61-6

  • 100g

  • 229.0CNY

  • Detail
  • Alfa Aesar

  • (A10101)  Ethyl salicylate, 99%   

  • 118-61-6

  • 500g

  • 441.0CNY

  • Detail
  • Alfa Aesar

  • (A10101)  Ethyl salicylate, 99%   

  • 118-61-6

  • 2500g

  • 1551.0CNY

  • Detail

118-61-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 2-hydroxybenzoate

1.2 Other means of identification

Product number -
Other names ethyl salicilate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118-61-6 SDS

118-61-6Synthetic route

2-(3-methyl-but-2-enyloxy)-benzoic acid ethyl ester

2-(3-methyl-but-2-enyloxy)-benzoic acid ethyl ester

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With titanium tetrachloride; tetra-(n-butyl)ammonium iodide In dichloromethane at -78℃; for 0.5h; deprenylation;100%
ethanol
64-17-5

ethanol

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With sulfuric acid for 4h; Reflux;99%
With sulfuric acid In water for 4h; Reflux;97.25%
With alumina methanesulfonic acid at 120℃; for 0.333333h; Microwave irradiation;96%
ethyl 2-oxocyclohexane carboxylate
1655-07-8

ethyl 2-oxocyclohexane carboxylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With palladium chloride*2MeCN; chloranil In 1,4-dioxane at 100℃; for 18h;95%
With 5-trimethylammonio-1,3-dioxo-1,3-dihydro-1λ5-benzo[d][1,2]-iodoxol-1-ol anion In diethylene glycol dimethyl ether; water at 40℃; for 24h;32%
ethyl acetylsalicylate
529-68-0

ethyl acetylsalicylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With Candida cylindracea lipase In di-isopropyl ether; butan-1-ol at 28 - 30℃; for 48h;94%
With aluminium trichloride; potassium iodide In water; acetonitrile at 80℃; for 4h;80%
2-(But-2-enyl-1-oxy)benzoesaeureethylester
61493-59-2

2-(But-2-enyl-1-oxy)benzoesaeureethylester

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With titanium tetrachloride; tetra-(n-butyl)ammonium iodide In dichloromethane at -78℃; for 0.5h; deprenylation;94%
ethanol
64-17-5

ethanol

methyl salicylate
119-36-8

methyl salicylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With potassium phosphate; N-benzyl-N,N,N-triethylammonium chloride at 20℃; for 4h;94%
ethyl iodide
75-03-6

ethyl iodide

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With cesium fluoride In acetonitrile for 3h; Heating;90%
diethyl sulfate
64-67-5

diethyl sulfate

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With sodium hydrogencarbonate; 3-butyl-1-methyl-1H-imidazol-3-ium hexafluorophosphate at 40℃; for 0.583333h;90%
ethanol
64-17-5

ethanol

2-methyl-benzyl alcohol
89-95-2

2-methyl-benzyl alcohol

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With perchloric acid; sodium percarbonate; vanadia for 4.5h; Cooling;89%
2-(o-Carboethxyphenoxy)-tetrahydropyran

2-(o-Carboethxyphenoxy)-tetrahydropyran

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In ethanol for 4h; Inert atmosphere; Reflux;83%
boron trifluoride diethyl etherate
109-63-7

boron trifluoride diethyl etherate

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
at 120℃; for 4h;78%
benzoic acid ethyl ester
93-89-0

benzoic acid ethyl ester

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With oxone; Ru(MesCO2)(4,4'-dibromobipyridine)(p-cymene); trifluoroacetic acid; trifluoroacetic anhydride In 1,2-dichloro-ethane at 85℃; for 6h; Reagent/catalyst; Sealed tube; Green chemistry; regioselective reaction;74%
With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; Selectfluor; trifluoroacetic acid; trifluoroacetic anhydride at 85℃; for 7.5h;73%
With palladium diacetate; 1-fluoro-pyridinium tetrafluoroborate; trifluoroacetic acid; trifluoroacetic anhydride at 90℃; for 8h; Sealed tube; regioselective reaction;69%
salicylic acid
69-72-7

salicylic acid

triethylphosphine
554-70-1

triethylphosphine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With 1,3-diazido-propane In neat (no solvent) at 20℃; for 0.333333h;74%
diethyl (trichloromethyl)phosphonate
866-23-9

diethyl (trichloromethyl)phosphonate

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
at 120℃; for 24h;72%
ethyl 3-oxohept-6-enoate
17605-06-0

ethyl 3-oxohept-6-enoate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With oxygen; copper diacetate; palladium diacetate In dimethyl sulfoxide at 45℃; under 760.051 Torr; for 23h; chemoselective reaction;71%
Stage #1: ethyl 3-oxohept-6-enoate With hydrogenchloride; palladium chloride*2MeCN; copper dichloride In 1,4-dioxane; water at 70℃; for 15h;
Stage #2: With chloranil at 100℃; for 18h;
60%
ethanol
64-17-5

ethanol

salicylaldehyde
90-02-8

salicylaldehyde

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With urea-2,2-dihydroperoxypropane; hydrogen bromide; acetic acid at 20℃; for 13h;68%
With dihydrogen peroxide at 60℃; for 3h;
With cation-exchange resin 001x7 modified with Ce(SO4)2 at 94.84℃; under 760.051 Torr; for 12h;
ethyl 2-methoxybenzoate
7335-26-4

ethyl 2-methoxybenzoate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With 2-(diethylamino)ethanethiol hydrochloride; sodium t-butanolate In N,N-dimethyl-formamide for 1h; Heating;56%
ethyl 2-oxocyclohex-3-ene-1-carboxylate
3400-80-4

ethyl 2-oxocyclohex-3-ene-1-carboxylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With 5-trimethylammonio-1,3-dioxo-1,3-dihydro-1λ5-benzo[d][1,2]-iodoxol-1-ol anion In diethylene glycol dimethyl ether; water at 40℃; for 24h;53%
2-(ethoxycarbonyl)phenylboronic acid
380430-53-5

2-(ethoxycarbonyl)phenylboronic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With [Rh2(bpy)2(μ-OAc)2(OAc)2]; oxygen; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide under 760.051 Torr; for 18h; Irradiation;50%
tetrachloromethane
56-23-5

tetrachloromethane

ethanol
64-17-5

ethanol

phenol
108-95-2

phenol

A

Ethyl 4-hydroxybenzoate
120-47-8

Ethyl 4-hydroxybenzoate

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With diiron nonacarbonyl at 130℃; for 6h; Inert atmosphere; Sealed tube;A 45%
B 28%
ethyl 6-acetoxy-6,7-dihydrooxepine-2-carboxylate
115957-48-7

ethyl 6-acetoxy-6,7-dihydrooxepine-2-carboxylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
at 610℃; under 5 Torr;28%
2,4,6-trimethyl-pyridine
108-75-8

2,4,6-trimethyl-pyridine

ethyl 1-chloro-2-oxocyclohexanecarboxylate
59736-20-8

ethyl 1-chloro-2-oxocyclohexanecarboxylate

A

cyclohexenone
930-68-7

cyclohexenone

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2,4,6-trimethyl-pyridine
108-75-8

2,4,6-trimethyl-pyridine

1-bromo-2-oxo-cyclohexanecarboxylic acid ethyl ester
34243-82-8

1-bromo-2-oxo-cyclohexanecarboxylic acid ethyl ester

A

ethyl 2-oxocyclohexane carboxylate
1655-07-8

ethyl 2-oxocyclohexane carboxylate

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 3-bromo-2-oxocyclohexanecarboxylate
30132-23-1

ethyl 3-bromo-2-oxocyclohexanecarboxylate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
at 220 - 240℃;
1-bromo-6-oxo-cyclohex-2-enecarboxylic acid ethyl ester

1-bromo-6-oxo-cyclohex-2-enecarboxylic acid ethyl ester

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

phenol
108-95-2

phenol

A

ethyl phenyl carbonate
3878-46-4

ethyl phenyl carbonate

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
unter verschiedenen Bedingungen;
1-bromo-2-oxo-cyclohexanecarboxylic acid ethyl ester
34243-82-8

1-bromo-2-oxo-cyclohexanecarboxylic acid ethyl ester

aniline
62-53-3

aniline

A

ethyl 2-oxocyclohexane carboxylate
1655-07-8

ethyl 2-oxocyclohexane carboxylate

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

phosphonic acid diethyl ester
762-04-9

phosphonic acid diethyl ester

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl ester of p-toluenesulfonic acid
80-40-0

ethyl ester of p-toluenesulfonic acid

salicylic acid
69-72-7

salicylic acid

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With sodium carbonate
ethanol
64-17-5

ethanol

CYANAMID
420-04-2

CYANAMID

salicylic acid
69-72-7

salicylic acid

A

urea
57-13-6

urea

B

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

propargyl bromide
106-96-7

propargyl bromide

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 2-(prop-2-yn-1-yloxy)benzoate
528599-00-0

ethyl 2-(prop-2-yn-1-yloxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran100%
With 18-crown-6 ether; potassium carbonate In N,N-dimethyl-formamide; toluene at 20℃; for 20h;
2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2-Hydroxybenzoylhydrazine
936-02-7

2-Hydroxybenzoylhydrazine

Conditions
ConditionsYield
With hydrazine hydrate In ethanol at 70℃; for 0.00111111h;99.1%
With hydrazine hydrate In ethanol; water Reflux;85%
With hydrazine hydrate In ethanol at 80℃; for 12h;82%
trifluoromethylsulfonic anhydride
358-23-6

trifluoromethylsulfonic anhydride

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2-trifluoromethylsulfonyloxybenzoic acid ethyl ester
179538-97-7

2-trifluoromethylsulfonyloxybenzoic acid ethyl ester

Conditions
ConditionsYield
With sodium hydride In hexane; dichloromethane at -78 - 0℃; for 18.5h;99%
With pyridine In dichloromethane at 20℃; for 0.5h;99%
With pyridine In dichloromethane at 0 - 20℃; Inert atmosphere;95%
Stage #1: 2-hydroxy-benzoic acid ethyl ester With sodium hydride In hexane; dichloromethane; mineral oil at 0℃; Inert atmosphere;
Stage #2: trifluoromethylsulfonic anhydride In hexane; dichloromethane; mineral oil at -78℃; Inert atmosphere;
90%
ethanolamine
141-43-5

ethanolamine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

N-(2-hydroxyethyl)salicylamide
24207-38-3

N-(2-hydroxyethyl)salicylamide

Conditions
ConditionsYield
In neat (no solvent) at 60℃; for 0.75h; Solvent; Temperature; Microwave irradiation; Green chemistry;99%
at 170℃; for 2h;
trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

C11H9F3O4

C11H9F3O4

Conditions
ConditionsYield
With triethylamine In dichloromethane at -78℃; for 4h; Inert atmosphere;99%
2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

3,5-dibromo-2-hydroxy-benzoic acid ethyl ester
64831-28-3

3,5-dibromo-2-hydroxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With benzyltrimethylammonium tribromide; calcium carbonate In methanol; dichloromethane98%
With bromine
2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

salicylonitrile
611-20-1

salicylonitrile

Conditions
ConditionsYield
With ammonia; boron phosphate at 400℃; for 0.000277778h;98%
Multi-step reaction with 2 steps
1: alcohol; ammonia / 100 °C
2: phosphorus pentoxide
View Scheme
Multi-step reaction with 2 steps
1: alcohol; ammonia / 100 °C
2: phosphorus pentoxide
View Scheme
Multi-step reaction with 3 steps
1: alcohol; ammonia / 100 °C
2: P2S5
3: bei der Destillation unter vermindertem Druck
View Scheme
fumaryl dichloride
627-63-4

fumaryl dichloride

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

bis-(2-(ethoxycarbonyl)phenyl) fumarate

bis-(2-(ethoxycarbonyl)phenyl) fumarate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 40℃; for 48h; Inert atmosphere;98%
n-Dodecylamine
124-22-1

n-Dodecylamine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

N-dodecyl-2-hydroxybenzamide
10586-70-6

N-dodecyl-2-hydroxybenzamide

Conditions
ConditionsYield
With phenylboronic acid In neat (no solvent) at 60℃; for 0.75h; Reagent/catalyst; Solvent; Microwave irradiation; Green chemistry;97%
With Candida antarctica lipase B In neat (no solvent) at 65℃; under 37.5038 Torr; for 20h; Catalytic behavior; Concentration; Green chemistry; Enzymatic reaction;99 %Chromat.
1-Heptylamine
111-68-2

1-Heptylamine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

N-heptyl-2-hydroxybenzamide

N-heptyl-2-hydroxybenzamide

Conditions
ConditionsYield
With phenylboronic acid In neat (no solvent) at 60℃; for 0.75h; Reagent/catalyst; Solvent; Microwave irradiation; Green chemistry;97%
allyl bromide
106-95-6

allyl bromide

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 2-(allyloxy)benzoate
61493-61-6

ethyl 2-(allyloxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In acetone for 18h; Reflux;96%
Stage #1: 2-hydroxy-benzoic acid ethyl ester With caesium carbonate In N,N-dimethyl-formamide
Stage #2: allyl bromide In N,N-dimethyl-formamide at 60℃; for 4h;
88%
With potassium carbonate In N,N-dimethyl-formamide for 21h; Ambient temperature;84%
methanol
67-56-1

methanol

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

methyl salicylate
119-36-8

methyl salicylate

Conditions
ConditionsYield
With di(n-butyl)tin oxide In methanol for 5h; Heating;96%
scandium tris(trifluoromethanesulfonate) at 64℃; for 144h;72%
ethyl bromoacetate
105-36-2

ethyl bromoacetate

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 2-(2-ethoxy-2-oxoethoxy)benzoate
56424-77-2

ethyl 2-(2-ethoxy-2-oxoethoxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃; for 3h; Williamson Ether Synthesis;96%
With potassium carbonate In acetone at 60℃; for 3h;96%
With potassium carbonate In acetone at 60℃; for 3h;96%
With potassium carbonate; sodium iodide In N,N-dimethyl-formamide at 20℃; for 24h;
2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

sodium salicylhydroxamic acid

sodium salicylhydroxamic acid

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium carbonate at 20℃; Milling;96%
1-(2-chloroethoxy)-3,5-dichlorothiatriazine
193969-76-5

1-(2-chloroethoxy)-3,5-dichlorothiatriazine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

3-chloro-1-(β-chloroethoxy)-5-(2'-carboethoxyphenoxy)thiatriazine

3-chloro-1-(β-chloroethoxy)-5-(2'-carboethoxyphenoxy)thiatriazine

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at -30℃;95%
benzyl bromide
100-39-0

benzyl bromide

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2-benzyloxy-benzoic acid ethyl ester
63888-93-7

2-benzyloxy-benzoic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 8h; Reflux; Inert atmosphere;94.71%
With potassium hydroxide In dimethyl sulfoxide at 45℃; for 5h; Alkylation;89.7%
(2,4-dinitro-phenyl)-hydrazine
119-26-6

(2,4-dinitro-phenyl)-hydrazine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

C13H10N4O6
79616-09-4

C13H10N4O6

Conditions
ConditionsYield
In ethanol at 20℃; for 2h;94%
1-octadecanol
112-92-5

1-octadecanol

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

octadecyl 2-hydroxybenzoate
14971-14-3

octadecyl 2-hydroxybenzoate

Conditions
ConditionsYield
With iron(III)-acetylacetonate In n-heptane at 105℃; for 35h; Inert atmosphere;94%
propan-1-ol-3-amine
156-87-6

propan-1-ol-3-amine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2–hydroxy–N-(3-hydroxypropyl)benzamide
91012-97-4

2–hydroxy–N-(3-hydroxypropyl)benzamide

Conditions
ConditionsYield
In hexane at 60℃; for 24h; Solvent;94%
for 4h; Reflux;
1-pentanamine
110-58-7

1-pentanamine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2-hydroxy-N-pentylbenzamide

2-hydroxy-N-pentylbenzamide

Conditions
ConditionsYield
With phenylboronic acid In neat (no solvent) at 60℃; for 0.75h; Reagent/catalyst; Solvent; Microwave irradiation; Green chemistry;94%
4-Vinylbenzyl chloride
1592-20-7

4-Vinylbenzyl chloride

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 2-((4-vinylbenzyl)oxy)benzoate

ethyl 2-((4-vinylbenzyl)oxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 24h;94%
dipropargyl ether
6921-27-3

dipropargyl ether

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

ethyl 2-(prop-2-yn-1-yloxy)benzoate
528599-00-0

ethyl 2-(prop-2-yn-1-yloxy)benzoate

Conditions
ConditionsYield
With potassium carbonate In acetone; toluene at 20℃;94%
Trimethylenediamine
109-76-2

Trimethylenediamine

2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

N,N'-bis(2-hydroxybenzoyl)-1,3-diaminopropane
24350-74-1

N,N'-bis(2-hydroxybenzoyl)-1,3-diaminopropane

Conditions
ConditionsYield
at 110℃; for 5h;93%
2-hydroxy-benzoic acid ethyl ester
118-61-6

2-hydroxy-benzoic acid ethyl ester

2-hydroxy-3,5-diiodobenzoic acid ethyl ester
528-15-4

2-hydroxy-3,5-diiodobenzoic acid ethyl ester

Conditions
ConditionsYield
With sodium hydrogencarbonate; N,N,N-trimethylbenzenemethanaminium dichloroiodate In methanol; dichloromethane for 7h; Ambient temperature;92%
With iodine; silver sulfate In ethanol at 20℃;78%

118-61-6Relevant articles and documents

-

Brenner,J.E.

, p. 22 - 27 (1961)

-

Design potential selective inhibitors for human leukocyte common antigen-related (PTP-LAR) with fragment replace approach

Li, Hong-Lian,Li, Wei-Ya,Lu, Xin-Hua,Ma, Ying,Tang, Xue,Wang, Run-Ling,Wu, Jing-Wei,Zhang, Huan,Zheng, Zhi-Hui

, p. 5338 - 5348 (2020)

The overexpression of PTP-LAR could cause the insulin resistance, so PTP-LAR might be a promising target for treating diabetes. In this study, we applied the computer modeling methods with fragment replace approach to screen the fragment database by targeting PTP domain and site B with the aim to discover potent and selective PTP-LAR inhibitors. A series of novel 4-thiazolidone derivatives were gained. The results of their ADMET predictions indicated that these new compounds might become drug candidates. The series of these derivatives were synthesized. Subsequently, their PTP-LAR inhibitory activities were assayed. The compound7d showed highly selectivity for PTP-LAR (10.41 μM) over its close homolog PTP1B (IC50=44.40 μM), SHP2 (IC50>122.81 μM) and CDC25B (IC50>122.81 μM) and docking and molecular dynamics simulation were applied to propose the most likely binding mode of compound7d with PTP-LAR. Thus, our findings reported here may pave a way for discovering potential selective PTP-LAR inhibitors. AbbreviationsPTP-LAR Human leukocyte common antigen-relatedPTP Protein Tyrosine PhosphataseIR insulin receptorPTP1B Protein tyrosine phosphatase-1BLRP Lung resistance proteinADMET absorption, distribution, metabolism, excretion, toxicityPPB plasma protein bindingBBB blood brain barrier penetrationCYP450 cytochrome P450HIA human intestinal absorptionTLC thin-layer chromatographyUV Ultra VioletNMR nuclear magnetic resonanceTMS tetramethylsilaneMS mass spectrometryANM anisotropic network modePDB Protein Data BankDMF N,N-DimethylformamidepNPP para-nitrophenyl phosphateDTT dithiothreitolMD molecular dynamicRMSD root-mean-square deviationRMSF root-mean-square fluctuationSPC single-point chargePME Particle Mesh EwaldMM-PBSA molecular mechanics Poisson Boltzmann surface areaH bond, hydrogen bondVDW Van der Waals Communicated by Ramaswamy H. Sarma.

SO3H-functionalized Bronsted acidic ionic liquids as efficient catalysts for the synthesis of isoamyl salicylate

Tao, Duan-Jian,Wu, Jing,Wang, Zhen-Zhen,Lu, Zhang-Hui,Yang, Zhen,Chen, Xiang-Shu

, p. 1 - 7 (2014)

Six Bronsted acidic ionic liquids (BAILs) composed of [HSO 4] were prepared, characterized, and used as catalysts of low dosage in the synthesis of isoamyl salicylate. The effects of various parameters such as the kind of BAILs, temperature, catalyst loading, and molar ratio of the reactants on the conversion of salicylic acid were also examined in detail. The results suggested that the catalytic performances of BAILs were of close relevance to their Hammett acidities. The SO3H-functionalized BAILs 1-(4-sulfonic acid) butyl-3-methylimidazolium hydrogen sulfate ([BSmim][HSO 4]) and N-(4-sulfonic acid) butyl triethylammonium hydrogen sulfate ([BSEt3N][HSO4]) of strong acidities exhibited excellently catalytic activities and selectivities in the esterification of salicylic acid with isoamyl alcohol. The fully optimized geometries of [BSmim][HSO4] and [BSEt3N][HSO4] further manifest that their strong acidities are derived from the strong interactions between the anion with the sulfonic acid group. In addition, it was found that [BSmim][HSO4] could be also recovered easily and used repetitively at least six times without obvious decline in activity and quantity.

Esterification of salicylic acid using Ce4+ modified cation-exchange resin as catalyst

Zhang, Ming,Zhu, Wen Shuai,Li, Hua Ming,Shi, Hua,Yan, Yong Sheng,Wang, Zhi Gao

, p. 1477 - 1481 (2012)

The esterification of salicylic acid with methanol was carried out over a series of Ce4+ modified cation-exchange resins. The effect of different reaction conditions was studied on the conversion of salicylic acid, and the optimal reaction parameters were obtained. The experimental results indicated that Ce(SO4)2/001×7 was an effective catalyst for the synthesis of methyl salicylate. The conversion of salicylic acid could reach 93.3% while its selectivity was more than 99.0%. SEM-EDS and TG-DSC analysis were employed to characterize the structure and property of the catalyst. Besides, the catalytic performance of Ce(SO4) 2/001×7 in the esterification of salicylic acid with different alcohols was compared. The reusability of Ce(SO4)2/ 001×7 was also studied by using salicylic acid and methanol as model substrates. The mechanism was proposed for the esterification of salicylic acid with methanol over Ce4+ modified cation-exchange resins.

Microwave-accelerated esterification of salicylic acid using Br?nsted acidic ionic liquids as catalysts

Shi, Hua,Zhu, Wenshuai,Li, Huaming,Liu, Hua,Zhang, Ming,Yan, Yongsheng,Wang, Zhigao

, p. 588 - 591 (2010)

A variety of Br?nsted acidic ionic liquids were screened as catalysts for the esterification of salicylic acid. The experimental results indicated that SO3H-functionalized ionic liquids with HSO4- performed high catalytic activity under microwave irradiation, and the yields can reach 91.9-93.6%. Furthermore, ionic liquids can be easily separated by simple decantation and have a fair reusability. The Br?nsted acidity-catalytic activity relationships were also investigated and the results showed that the activity of the acidic ionic liquids is in excellent agreement with their acidity order. Crown Copyright

A polynuclear Cu(ii) complex for real time monitoring of mitochondrial cytochrome: C release during cellular apoptosis

Brand?o, Paula,Das, Debasis,Félix, Vítor,Ghosh, Milan,Ghosh, Subhasis,Hira, Sumit Kumar,Khanra, Somnath,Manna, Partha Partim,Paladhi, Ankush,Ta, Sabyasachi

, p. 6563 - 6566 (2020)

A new amide-imine conjugate, 2-hydroxybenzoic acid-(2-hydroxybenzylidene)-hydrazide (L1), is employed to prepare a single crystal X-ray structurally characterized poly-nuclear Cu(ii) complex (M1). M1 selectively and spatially interacts with cytochrome C (Cyt C) to allow fluorescence imaging of intracellular translocation events in living cells. Thus, direct visualization of a Cyt C translocation event during an apoptotic process is achieved for the first time. The binding constant and LOD are 7.52 × 104 M-1 and 34.0 nM, respectively.

Pleuromutilin derivative with 1, 3, 4-oxadiazole side chain and preparation and application thereof

-

Paragraph 0055-0056; 0070; 0090; 0092; 0095; 0103, (2021/07/24)

The invention belongs to the field of medicinal chemistry, and particularly relates to a pleuromutilin derivative with a 1, 3, 4-oxadiazole side chain and preparation and application thereof The pleuromutilin derivative with the 1, 3, 4-oxadiazole side chain is a compound shown in a formula 2 or a pharmaceutically acceptable salt thereof, and a solvent compound, an enantiomer, a diastereoisomer and a tautomer of the compound shown in the formula 2 or the pharmaceutically acceptable salt thereof or a mixture of the solvent compound, the enantiomer, the diastereoisomer and the tautomer in any proportion, including a racemic mixture. The pleuromutilin derivative has good antibacterial activity, is especially suitable for being used as a novel antibacterial agent for systemic system infection of animals or human beings, and has good water solubility.

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker

Liu, Jie,Zhang, Guang-Yu,Zhang, Zhe,Li, Bo,Chai, Fei,Wang, Qi,Zhou, Zi-Dan,Xu, Ling-Ling,Wang, Shou-Kai,Jin, Zhen,Tang, You-Zhi

, (2021/05/17)

A class of pleuromutilin derivatives containing 1, 3, 4-oxadiazole were designed and synthesized as potential antibacterial agents against Methicillin-resistant staphylococcus aureus (MRSA). The ultrasound-assisted reaction was proposed as a green chemistry method to synthesize 1, 3, 4-oxadiazole derivatives (intermediates 85–110). Among these pleuromutilin derivatives, compound 133 was found to be the strongest antibacterial derivative against MRSA (MIC = 0.125 μg/mL). Furthermore, the result of the time-kill curves displayed that compound 133 could inhibit the growth of MRSA in vitro quickly (- 4.36 log10 CFU/mL reduction). Then, compound 133 (- 1.82 log10 CFU/mL) displayed superior in vivo antibacterial efficacy than tiamulin (- 0.82 log10 CFU/mL) in reducing MRSA load in mice thigh model. Besides, compound 133 exhibited low cytotoxicity to RAW 264.7 cells. Molecular docking studies revealed that compound 133 was successfully localized in the binding pocket of 50S ribosomal subunit (ΔGb = -10.50 kcal/mol). The results indicated that these pleuromutilin derivatives containing 1, 3, 4-oxadiazole might be further developed into novel antibiotics against MRSA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 118-61-6